Skip to main content

D. E. Shaw & Co., Inc.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1009207 New York, NY

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,450,565
-$9,194,003 QoQ
Shares Held
1,623,281
-15.2% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 168 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 99.20254102647662.ToString("F0")% Shared 0.ToString("F0")% None 0.7974589735233764.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,382,181,531 across 180 Biotechnology names. FULC ranks #57 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,450,565 1,623,281
2025-12-31 $21,644,568 1,913,755
2025-09-30 $13,334,691 1,449,423
2025-06-30 $8,095,771 1,176,711
2025-03-31 $1,672,303 580,661
2024-12-31 $2,741,054 583,203
2024-09-30 $2,705,099 757,731
2024-06-30 $3,669,066 591,785
2024-03-31 $5,901,660 625,176
2023-12-31 $3,359,332 497,679
2023-09-30 $982,411 221,264
2023-06-30 $482,532 146,222
2023-03-31 $43,670 15,323
2022-12-31 $1,282,342 176,146
2022-09-30 $666,122 82,339
2022-06-30 $683,461 139,482
2022-03-31 $12,946,104 547,404
2021-12-31 $15,074,498 852,148
2021-09-30 $22,514,429 798,101